Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria

British Journal of Dermatology

Volumn 149, Issue 4, 2003, Pages 836-840

  Dawn, G ^a   Urcelay, M ^a   Ah Weng, A ^a   O'Neill, S M ^b   Douglas, W S ^a  

^a MONKLANDS HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Delayed positive autologous serum skin test; Delayed pressure urticaria; Intravenous immunoglobulin

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DAPSONE; IMMUNOGLOBULIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOLOGOUS SERUM SKIN TEST; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; DRUG INFUSION; DRUG MEGADOSE; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HUMAN; MALAISE; MALE; NAUSEA; PREDICTION; PRESSURE URTICARIA; PRIORITY JOURNAL; REMISSION; SKIN TEST; SYMPTOMATOLOGY; URTICARIA;

ADULT; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; PRESSURE; SKIN TESTS; TIME FACTORS; TREATMENT OUTCOME; URTICARIA;

EID: 0242550817     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05486.x     Document Type: Article

References (24)

1. Kobza-Black A, Champion RH. Urticaria. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA, Breathnach SM, eds), 6th edn, Vol. 3. Oxford: Blackwell Science, 1998: 2113-39.
2. Kontou-Fili K, Borici-Mazi R, Kapp A et al. Physical urticaria: classification and diagnostic guidelines. An EAACI position paper. Allergy 1997; 52: 504-13.
3. Sussman GL, Harvey RP, Schocket AL. Delayed pressure urticaria. J Allergy Clin Immunol 1982; 70: 337-42.
4. O'Donnell BF, Lawlor F, Simpson J et al. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
5. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140: 667-71.
6. Fili-Kontou K, Maniatakou G, Demaka P et al. Therapeutic effects of cetirizine in delayed pressure urticaria: clinicopathologic findings. J Am Acad Dermatol 1991; 24: 1090-3.
7. Dover JS, Black AK, Ward AM, Greaves MW. Delayed pressure urticaria. Clinical features, laboratory investigations, and response to therapy of 44 patients. J Am Acad Dermatol 1988; 18: 1289-98.
8. Lawlor F, Black AK, Ward AM et al. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermatol 1989; 120: 403-8.
9. Engler RJ, Squire E, Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol 1995; 74: 155-9.
10. Kruger-Krasagakes S, Henz BM. Delayed pressure urticaria. In: Urticaria; Clinical, Diagnostic and Therapeutic Aspects (Henz BM, Zuberbier Grabe J, Monroe E, eds), Heidelberg: Springer-Verlag, 1998: 64-8.
11. Barlow RJ, Macdonald DM, Black AK, Greaves MW. The effects of topical corticosteroids on delayed pressure urticaria. Arch Dermatol Res 1995; 287: 285-8.
12. O'Donnell BF, Barr RM, Kobza Black A et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998; 138: 101-6.
13. Rutter A, Luger TA. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. J Am Acad Dermatol 2001; 44: 1010-24.
14. Jolles S. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders. Clin Exp Dermatol 2001; 26: 127-31.
15. Urcelay ML, McQueen A, Douglas WS. Cicatricial pemphigoid treated with intravenous immunoglobulin. Br J Dermatol 1997; 137: 477-8.
16. Urcelay ML, Clark C, Lambe D et al. Experience with intravenous immunoglobulin in severe dermatosis. J Eur Acad Dermatol Venereol 1997; 9 (Suppl. 1): S156 (Abstr.).
17. Dawn G, Urcelay M, O'Neill SM, Douglas WS. Intravenous immunoglobulin in chronic urticaria. Clin Exp Dermatol 2002; 27: 254 (Abstr.).
18. Kobza-Black A. Delayed pressure urticaria. Symposium proceedings. J Invest Dermatol 2001; 6: 148-9.
19. Sabroe RA, Grattan CEH, Francis DM et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 446-52.
20. Ratko TA, Burnett DA, Foulke GE et al. Recommendations for off-label use of intravenously administered immunoglobulin preparations. JAMA 1995; 273: 1865-70.
21. Niimi N, Francis DM, Kermani F et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996; 106: 1001-6.
22. Hide M, Francis DM, Grattan CEH et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993; 328: 1599-604.
23. Grattan CEH, O'Donnell BF, Francis DM et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000; 143: 365-72.
24. Grattan CEH, Francis DM, Slater NGP et al. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992; 339: 1078-80.